Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | PLG | P00747 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | GSR | P00390 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | GRM8 | O00222 | 1/20 | 0.54 |
| ▸ | GRM6 | O15303 | 1/20 | 0.54 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.54 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2750074 | 0.94 | LMNA (0.56) | CYP2D6NFKB1LMNABLMNPSR1 | |
| SCHEMBL3959872 | 0.89 | LMNA (0.63) | CYP2D6NFKB1LMNABLMNPSR1 | |
| SCHEMBL29622843 | 0.89 | LMNA (0.63) | CYP2D6NFKB1LMNABLMNPSR1 | |
| SCHEMBL29622881 | 0.89 | LMNA (0.63) | CYP2D6NFKB1LMNABLMNPSR1 | |
| SCHEMBL30914234 | 0.88 | GRM8 (0.58) | CYP2D6NFKB1LMNATHRBKMT2A | |
| SCHEMBL15569584 | 0.88 | GRM8 (0.58) | CYP2D6NFKB1LMNATHRBKMT2A | |
| SCHEMBL31088659 | 0.88 | GRM8 (0.58) | CYP2D6NFKB1LMNATHRBKMT2A | |
| SCHEMBL31171172 | 0.88 | GRM8 (0.58) | CYP2D6NFKB1LMNATHRBKMT2A | |
| SCHEMBL16950119 | 0.85 | CYP1A2 (0.60) | CYP2D6NFKB1LMNABLMNPSR1 | |
| Glutamic Acid SCHEMBL15300086 | 0.84 | GSR (0.72) | CYP2D6NFKB1LMNABLMNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220054590-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE THEREOF | JANSSEN BIOTECH, INC. | 2022-02-24 | — | — | US | claimed |
| US-11083776-B2 | Protoxin-II variants and methods of use | JANSSEN BIOTECH, INC. (US) | 2021-08-10 | — | — | US | claimed |
| US-20200054712-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH, INC. | 2020-02-20 | — | — | US | claimed |
| US-10463714-B2 | Protoxin-II variants and methods of use | JANSSEN BIOTECH, INC. (US) | 2019-11-05 | — | — | US | claimed |
| EP-3277304-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE | Janssen Biotech, Inc. (US) | 2018-02-07 | — | — | EP | claimed |
| WO-2016161100-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH, INC. (US) | 2016-10-06 | — | — | WO | claimed |
| US-20160287666-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH, INC. | 2016-10-06 | — | — | US | claimed |
| US-7279149-B2 | Amino acid composition with increased blood brain barrier permeability | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2007-10-09 | — | — | US | claimed |
| WO-2005042005-A1 | AMINO ACID COMPOSITION WITH INCREASED BLOOD BRAIN BARRIER PERMEABILITY | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2005-05-12 | — | — | WO | claimed |
| US-20050095201-A1 | Amino acid composition with increased blood brain barrier permeability | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2005-05-05 | — | — | US | claimed |
| US-20220054590-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE THEREOF | JANSSEN BIOTECH, INC. | 2022-02-24 | — | — | US | disclosed |
| US-20210363204-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH, INC. | 2021-11-25 | — | — | US | disclosed |
| US-11083776-B2 | Protoxin-II variants and methods of use | JANSSEN BIOTECH, INC. (US) | 2021-08-10 | — | — | US | disclosed |
| EP-3277304-B1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH INC (US) | 2021-08-04 | — | — | EP | disclosed |
| US-20200054712-A1 | PROTOXIN-II VARIANTS AND METHODS OF USE | JANSSEN BIOTECH, INC. | 2020-02-20 | — | — | US | disclosed |
| US-7279149-B2 | Amino acid composition with increased blood brain barrier permeability | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2007-10-09 | — | — | US | disclosed |
| WO-2005042005-A1 | AMINO ACID COMPOSITION WITH INCREASED BLOOD BRAIN BARRIER PERMEABILITY | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2005-05-12 | — | — | WO | disclosed |
| WO-2005042005-A1 | AMINO ACID COMPOSITION WITH INCREASED BLOOD BRAIN BARRIER PERMEABILITY | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2005-05-12 | — | — | WO | disclosed |
| US-20050095201-A1 | Amino acid composition with increased blood brain barrier permeability | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2005-05-05 | — | — | US | disclosed |
| US-20050095201-A1 | Amino acid composition with increased blood brain barrier permeability | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2005-05-05 | — | — | US | disclosed |